Dr. Robert Cunningham Gerring, MD

Dr. Gerring practices at ENT and Allergy Associates of Florida in Boca Raton, Florida.

Dr. Gerring's NPI, 1457640054, was assigned on April 4, 2011. Dr. Gerring graduated from University of Miami, Miller School of Medicine in 2011. Dr. Gerring holds Florida license ME133731.

Dr. Gerring's primary practice is ENT and Allergy Associates of Florida, at 900 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 338-3267.

Dr. Gerring's primary practice is ENT and Allergy Associates of Florida in Boca Raton, Florida. Dr. Gerring is also affiliated with Jupiter Medical Center. The medical group on file is ENT & Allergy Associates of Florida. Dmand AI also links Dr. Gerring to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gerring practices, 4 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Gerring's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Gerring is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Gerring's licenses on file in 2 states: Florida and Pennsylvania.

Dmand AI lists chronic ear infection, chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment and larynx and vocal cord disease among the conditions Dr. Gerring treats.

CMS data shows 8,125 Medicare services from Dr. Gerring across 18 procedure codes in 2024, for 686 Medicare patients. Medicare paid $378,730 for them.

CMS counts 686 Medicare patients who saw Dr. Gerring in 2024. The largest group is 65 to 74, with 284 patients. 75% of them have high cholesterol, and 70% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.29, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gerring's median patient age at 67, with 56% women.

In 2024, Dr. Gerring wrote 1,614 Medicare Part D claims for 532 patients. 96% of them were for generic drugs. CMS names the drug for 1,503 of them, across 23 drugs with 11 or more claims each, at $22,643 in total drug cost. In 2023, CMS named 944 claims across 19 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gerring for performance year 2024, reported individually. Dr. Gerring accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Upper gastrointestinal (GI) endoscopy for acid reflux: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 7 papers to Dr. Gerring, published from 2011 to 2017. 2014 was the busiest year, with 3. The most frequent topics are Ear, Middle and Skin Neoplasms. Dr. Gerring has published most often in Eye (Lond). Dr. Gerring's most frequent co-authors are Xue Zhong Liu, MD, Zoukaa B. Sargi, MD and Simon I. Angeli, MD.

CMS Open Payments shows 171 general payments to Dr. Gerring from 23 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 85% of the total. Stryker Corporation paid the most, $2,822.

Dr. Gerring graduated from University of Miami, Miller School of Medicine in 2011.

Dr. Gerring is in network with 18 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.